Semax for Sale — Lab-Tested Semax at 99.3% HPLC Purity

Semax 10mg research peptide vial from Amino Fuel Labs

Semax is a acth-derived heptapeptide supplied by Amino Fuel Labs for laboratory research in nootropic and cognition research, bdnf and neurotrophin expression studies, stroke and ischemia recovery research. This listing covers a single lyophilized powder configuration, each released against a batch-specific third-party Certificate of Analysis reporting 99.5% purity by reversed-phase HPLC. Vials ship from our US facility with lot documentation matching the exact batch you receive. Research use only.

$55.00 — In stock, ships same business day

Semax Research Overview

Semax is a synthetic heptapeptide derived from ACTH(4-10) with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Developed in the Russian Academy of Medical Sciences in the 1980s, it is included in Russia's Vital and Essential Drugs List for stroke and cognitive disorders.

Available Semax Research Strengths

Purity and Laboratory Testing

Lot AFL-SEMAX-2026-001 (tested 2026-03-07) of Semax was assayed by an independent laboratory using reversed-phase HPLC for purity and mass spectrometry for identity confirmation, returning 99.5% purity. The Certificate of Analysis shipped in the box matches the lot number printed on the vial.

Technical Product Information

Molecular formula C₃₇H₅₁N₉O₁₀, molecular weight 813.86 g/mol, sequence Met-Glu-His-Phe-Pro-Gly-Pro. Semax modulates BDNF and NGF expression in the hippocampus, increases dopamine and serotonin turnover, and inhibits enkephalin degradation. It also shows neuroprotective effects via attenuation of glutamate excitotoxicity and oxidative stress in ischemic models. Semax is supplied as lyophilized powder and is classified in our catalog under acth-derived heptapeptide for acth-derived heptapeptide work. Recorded research categories for this compound include nootropic and cognition research, bdnf and neurotrophin expression studies, stroke and ischemia recovery research, adhd and focus research. Handling notes: store at -20°c (freezer), protect the vial from light, and avoid repeated freeze–thaw cycles once reconstituted. Amino Fuel Labs publishes no dosing protocol for Semax: the compound is distributed for in-vitro and preclinical laboratory research only and is not intended for human or veterinary use.

Certificate of Analysis

View the Semax Certificate of Analysis for the current lot, including HPLC purity and mass-spectrometry identity data.

Frequently Asked Questions

What's the difference between Semax and Selank?

Semax is derived from ACTH and primarily upregulates BDNF and dopamine signaling — researched for focus and cognition. Selank is derived from tuftsin and acts on GABA pathways — researched for anxiety reduction.

Is Semax approved as a medication?

Semax is approved in Russia for stroke recovery and cognitive disorders. In the US, Europe and most of the world it is sold only as a research chemical.

What purity does this Semax test at?

Every batch is HPLC-verified at ≥99.5% and ships with a third-party Certificate of Analysis.

What is Semax studied for?

Semax appears in laboratory research covering cognitive enhancement, memory research, neuroprotection. All references describe in-vitro and preclinical study models only.

Does Semax include a Certificate of Analysis?

Yes. Each Semax lot ships with a batch-specific third-party Certificate of Analysis reporting 99.5% purity by reversed-phase HPLC alongside mass-spectrometry identity confirmation.

What form does Semax arrive in?

Semax is supplied as lyophilized powder in a sealed vial, packed with the lot documentation for the exact batch shipped.

Related Research Products

Research Use Only

Semax is supplied strictly for laboratory research use. It is not a drug, food or cosmetic and is not intended for human or veterinary use, consumption, diagnosis, treatment or prevention of any condition. Amino Fuel Labs publishes no human dosing or administration guidance.

Browse all research peptides for sale · View third-party lab reports · Read the research peptide FAQ